Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study | PLOS Medicine
Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment - Frontiers
Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury | Journal of Neurology, Neurosurgery & Psychiatry
Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease | Scientific Data
BIOCHEMICAL MARKERS FOR MYOCARDIAL INFARCTION – Histopathology.guru
Biomedicines | Free Full-Text | Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions
Pathology of brain tumours: the current state of diagnostic practice
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity | Fluids and Barriers of the CNS | Full Text
Determinants of seeding and spreading of α-synuclein pathology in the brain | Science Advances
Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau | Neuropsychopharmacology
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine